Grants per year
Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
HORMONAL REGULATION OF CARCINOGENESIS IN TROUT
Nelson, M. A. (PI) & Buhler, D. (PI)
3/1/91 → …
Project: Research project
-
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Rimsza, L. M. (PI)
Project: Research project
-
-
Albumin 20% in surgical and critically ill patients; a comprehensive review
Hahn, R. G., Jardot, F., Dull, R. O., Zdolsek, J. & Wuethrich, P. Y., Dec 2026, In: Critical Care. 30, 1, 165.Research output: Contribution to journal › Review article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Clinicopathologic Analyses of 34 Cases of High-Grade Serous-Like Carcinoma (HG-SL-Ca) of the Breast
Haw, Y., Krings, G., Hsiao, W. Y., Zhan, H., Hou, Y., Zhang, G., Zhang, H., Wei, S., Yang, W., Laé, M., Post, M. D., Liu, Y., Shamir, E. R., Rosa, M., Siziopikou, K., Schnitt, S., Chen, Y. Y. & Li, X., Feb 25 2026, In: American Journal of Surgical Pathology. Publish Ahead of PrintResearch output: Contribution to journal › Article › peer-review
-
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma
Filip, D., Litzmanova, K., Michaelou, A., Kledus, F., Devan, J., Boudny, M., Hoferkova, E., Sharma, S., Seda, V., Zeni, P. F., Borsky, M., Matulova, K., Kren, L., Oppelt, J., Blavet, N., Hejret, V., Urik, M., Mareckova, A., Rimsza, L. M. & Kamaradova, K. & 14 others, , Apr 2026, In: Leukemia. 40, 4, p. 759-772 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations
Datasets
-
Supplementary Material for: A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma
Puvvada, S. D. (Creator), Guillén-Rodríguez, J. M. (Creator), Rivera, X. I. (Creator), Heard, K. (Creator), Inclan, L. (Creator), Schmelz, M. (Creator), Schatz, J. H. (Creator) & Persky, D. O. (Creator), figshare, 2017
DOI: 10.6084/m9.figshare.5373199, https://karger.figshare.com/articles/figure/Supplementary_Material_for_A_Phase_II_Exploratory_Study_of_PXD-101_Belinostat_Followed_by_Zevalin_in_Patients_with_Relapsed_Aggressive_High-Risk_Lymphoma/5373199
Dataset
-
Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease
Vrba, L. (Creator), Futscher, B. W. (Creator), Oshiro, M. (Creator), Watts, G. S. (Creator), Menashi, E. (Creator), Hu, C. (Creator), Hammad, H. (Creator), Pennington, D. R. (Creator), Golconda, U. (Creator), Gavini, H. (Creator), Roe, D. J. (Creator), Shroff, R. T. (Creator) & Nelson, M. A. (Creator), figshare, 2022
DOI: 10.6084/m9.figshare.c.5855943.v1, https://springernature.figshare.com/collections/Liquid_biopsy_using_a_novel_DNA_methylation_signature_distinguishes_pancreatic_adenocarcinoma_from_benign_pancreatic_disease/5855943/1
Dataset
-
Supplementary Material for: A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma
Puvvada, S. D. (Creator), Guillén-Rodríguez, J. M. (Creator), Rivera, X. I. (Creator), Heard, K. (Creator), Inclan, L. (Creator), Schmelz, M. (Creator), Schatz, J. H. (Creator) & Persky, D. O. (Creator), Karger Publishers, 2017
DOI: 10.6084/m9.figshare.5373199.v1, https://karger.figshare.com/articles/figure/Supplementary_Material_for_A_Phase_II_Exploratory_Study_of_PXD-101_Belinostat_Followed_by_Zevalin_in_Patients_with_Relapsed_Aggressive_High-Risk_Lymphoma/5373199/1
Dataset